TY - JOUR AU - Little, E. G. AU - Eide, M. J. PY - 2012 DA - 2012// TI - Update on the current state of melanoma incidence JO - Dermatol Clin VL - 30 UR - https://doi.org/10.1016/j.det.2012.04.001 DO - 10.1016/j.det.2012.04.001 ID - Little2012 ER - TY - JOUR AU - Franceschi, S. AU - Vecchia, C. AU - Lucchini, F. PY - 1991 DA - 1991// TI - The epidemiology of cutaneous malignant melanoma: aetiology and European data JO - Eur J Cancer Prev VL - 1 UR - https://doi.org/10.1097/00008469-199110000-00003 DO - 10.1097/00008469-199110000-00003 ID - Franceschi1991 ER - TY - JOUR AU - Armstrong, B. K. AU - Kricker, A. PY - 1994 DA - 1994// TI - Cutaneous melanoma JO - Cancer Surv VL - 19–20 ID - Armstrong1994 ER - TY - JOUR AU - Giblin, A. V. AU - Thomas, J. M. PY - 2007 DA - 2007// TI - Incidence, mortality and survival in cutaneous melanoma JO - J Plast Reconstr Aesthet Surg VL - 60 UR - https://doi.org/10.1016/j.bjps.2006.05.008 DO - 10.1016/j.bjps.2006.05.008 ID - Giblin2007 ER - TY - JOUR AU - Lee, K. C. AU - Higgins, H. W. AU - Qureshi, A. A. PY - 2015 DA - 2015// TI - Familial risk of melanoma and links with other cancers JO - Melanoma Manag VL - 2 UR - https://doi.org/10.2217/mmt.14.34 DO - 10.2217/mmt.14.34 ID - Lee2015 ER - TY - JOUR AU - Bommareddy, P. K. AU - Silk, A. W. AU - Kaufman, H. L. PY - 2017 DA - 2017// TI - Intratumoral approaches for the treatment of melanoma JO - Cancer J VL - 23 UR - https://doi.org/10.1097/PPO.0000000000000234 DO - 10.1097/PPO.0000000000000234 ID - Bommareddy2017 ER - TY - JOUR AU - Mishra, H. AU - Mishra, P. K. AU - Ekielski, A. PY - 2018 DA - 2018// TI - Melanoma treatment: from conventional to nanotechnology JO - J Cancer Res Clin Oncol VL - 144 UR - https://doi.org/10.1007/s00432-018-2726-1 DO - 10.1007/s00432-018-2726-1 ID - Mishra2018 ER - TY - JOUR AU - Testori, A. AU - Ribero, S. AU - Bataille, V. PY - 2017 DA - 2017// TI - Diagnosis and treatment of in-transit melanoma metastases JO - Eur J Surg Oncol VL - 43 UR - https://doi.org/10.1016/j.ejso.2016.10.005 DO - 10.1016/j.ejso.2016.10.005 ID - Testori2017 ER - TY - JOUR AU - Chattopadhyay, C. AU - Kim, D. W. AU - Gombos, D. S. PY - 2016 DA - 2016// TI - Uveal melanoma: from diagnosis to treatment and the science in between JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.29727 DO - 10.1002/cncr.29727 ID - Chattopadhyay2016 ER - TY - JOUR AU - Peng, W. X. AU - Koirala, P. AU - Mo, Y. Y. PY - 2017 DA - 2017// TI - LncRNA-mediated regulation of cell signaling in cancer JO - Oncogene VL - 36 UR - https://doi.org/10.1038/onc.2017.184 DO - 10.1038/onc.2017.184 ID - Peng2017 ER - TY - JOUR AU - Huarte, M. PY - 2015 DA - 2015// TI - The emerging role of lncRNAs in cancer JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3981 DO - 10.1038/nm.3981 ID - Huarte2015 ER - TY - JOUR AU - Li, D. AU - Tang, X. AU - Li, M. PY - 2019 DA - 2019// TI - Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p JO - J Cell Biochem VL - 120 UR - https://doi.org/10.1002/jcb.28493 DO - 10.1002/jcb.28493 ID - Li2019 ER - TY - JOUR AU - Jin, Z. AU - Jiang, S. AU - Jian, S. PY - 2019 DA - 2019// TI - Long noncoding RNA MORT overexpression inhibits cancer cell proliferation in oral squamous cell carcinoma by downregulating ROCK1 JO - J Cell Biochem UR - https://doi.org/10.1002/jcb.28449 DO - 10.1002/jcb.28449 ID - Jin2019 ER - TY - JOUR AU - Jiang, X. AU - Li, Q. AU - Zhang, S. PY - 2019 DA - 2019// TI - Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer JO - Onco Targets Ther VL - 12 UR - https://doi.org/10.2147/OTT.S192290 DO - 10.2147/OTT.S192290 ID - Jiang2019 ER - TY - JOUR AU - Al-Rugeebah, A. AU - Alanazi, M. AU - Parine, N. R. PY - 2019 DA - 2019// TI - MEG3: an oncogenic long non-coding RNA in different cancers JO - Pathol Oncol Res UR - https://doi.org/10.1007/s12253-019-00614-3 DO - 10.1007/s12253-019-00614-3 ID - Al-Rugeebah2019 ER - TY - JOUR AU - Wu, M. AU - Huang, Y. AU - Chen, T. PY - 2019 DA - 2019// TI - LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis JO - J Cell Mol Med VL - 23 UR - https://doi.org/10.1111/jcmm.13658 DO - 10.1111/jcmm.13658 ID - Wu2019 ER - TY - JOUR AU - Dong, X. AU - Wang, J. AU - Li, T. PY - 2018 DA - 2018// TI - Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-beta1 and its downstream sphingosine kinase 1 JO - Eur Rev Med Pharmacol Sci VL - 22 ID - Dong2018 ER - TY - JOUR AU - Dai, Y. AU - Wan, Y. AU - Qiu, M. PY - 2018 DA - 2018// TI - lncRNA MEG3 suppresses the tumorigenesis of hemangioma by sponging miR-494 and regulating PTEN/PI3K/AKT pathway JO - Cell Physiol Biochem VL - 51 UR - https://doi.org/10.1159/000496040 DO - 10.1159/000496040 ID - Dai2018 ER - TY - JOUR AU - Long, J. AU - Pi, X. PY - 2018 DA - 2018// TI - lncRNA-MEG3 suppresses the proliferation and invasion of melanoma by regulating CYLD expression mediated by sponging miR-499-5p JO - Biomed Res Int VL - 2018 UR - https://doi.org/10.1155/2018/2086564 DO - 10.1155/2018/2086564 ID - Long2018 ER - TY - JOUR AU - Melnik, B. C. PY - 2015 DA - 2015// TI - MiR-21: an environmental driver of malignant melanoma? JO - J Transl Med VL - 13 UR - https://doi.org/10.1186/s12967-015-0570-5 DO - 10.1186/s12967-015-0570-5 ID - Melnik2015 ER - TY - JOUR AU - Saldanha, G. AU - Potter, L. AU - Lee, Y. S. PY - 2016 DA - 2016// TI - MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma JO - Melanoma Res VL - 26 UR - https://doi.org/10.1097/CMR.0000000000000216 DO - 10.1097/CMR.0000000000000216 ID - Saldanha2016 ER - TY - JOUR AU - Ciolczyk-Wierzbicka, D. AU - Laidler, P. PY - 2018 DA - 2018// TI - The inhibition of invasion of human melanoma cells through N-cadherin knock-down JO - Med Oncol VL - 35 UR - https://doi.org/10.1007/s12032-018-1104-9 DO - 10.1007/s12032-018-1104-9 ID - Ciolczyk-Wierzbicka2018 ER - TY - JOUR AU - Read, J. AU - Wadt, K. A. AU - Hayward, N. K. PY - 2016 DA - 2016// TI - Melanoma genetics JO - J Med Genet VL - 53 UR - https://doi.org/10.1136/jmedgenet-2015-103150 DO - 10.1136/jmedgenet-2015-103150 ID - Read2016 ER - TY - JOUR AU - Read, J. PY - 2013 DA - 2013// TI - Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment JO - Aust J Dermatol VL - 54 UR - https://doi.org/10.1111/ajd.12013 DO - 10.1111/ajd.12013 ID - Read2013 ER - TY - JOUR AU - Potrony, M. AU - Badenas, C. AU - Aguilera, P. PY - 2015 DA - 2015// TI - Update in genetic susceptibility in melanoma JO - Ann Transl Med VL - 3 ID - Potrony2015 ER - TY - JOUR AU - Yu, X. AU - Zheng, H. AU - Tse, G. PY - 2018 DA - 2018// TI - Long non-coding RNAs in melanoma JO - Cell Prolif VL - 51 UR - https://doi.org/10.1111/cpr.12457 DO - 10.1111/cpr.12457 ID - Yu2018 ER - TY - JOUR AU - Zhou, Y. AU - Zhang, X. AU - Klibanski, A. PY - 2012 DA - 2012// TI - MEG3 noncoding RNA: a tumor suppressor JO - J Mol Endocrinol VL - 48 UR - https://doi.org/10.1530/JME-12-0008 DO - 10.1530/JME-12-0008 ID - Zhou2012 ER - TY - JOUR AU - Balik, V. AU - Srovnal, J. AU - Sulla, I. PY - 2013 DA - 2013// TI - MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas JO - J Neurooncol VL - 112 UR - https://doi.org/10.1007/s11060-012-1038-6 DO - 10.1007/s11060-012-1038-6 ID - Balik2013 ER - TY - JOUR AU - Zhang, Y. AU - Wu, J. AU - Jing, H. PY - 2019 DA - 2019// TI - Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-kappaB and p53 JO - J Cell Biochem VL - 120 UR - https://doi.org/10.1002/jcb.27982 DO - 10.1002/jcb.27982 ID - Zhang2019 ER - TY - JOUR AU - Wang, J. AU - Xu, W. AU - He, Y. PY - 2018 DA - 2018// TI - LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN JO - Inflamm Res VL - 67 UR - https://doi.org/10.1007/s00011-018-1186-z DO - 10.1007/s00011-018-1186-z ID - Wang2018 ER - TY - JOUR AU - Kourtidis, A. AU - Lu, R. AU - Pence, L. J. PY - 2017 DA - 2017// TI - A central role for cadherin signaling in cancer JO - Exp Cell Res VL - 358 UR - https://doi.org/10.1016/j.yexcr.2017.04.006 DO - 10.1016/j.yexcr.2017.04.006 ID - Kourtidis2017 ER - TY - JOUR AU - Gloushankova, N. A. AU - Rubtsova, S. N. AU - Zhitnyak, I. Y. PY - 2017 DA - 2017// TI - Cadherin-mediated cell-cell interactions in normal and cancer cells JO - Tissue Barriers VL - 5 UR - https://doi.org/10.1080/21688370.2017.1356900 DO - 10.1080/21688370.2017.1356900 ID - Gloushankova2017 ER - TY - JOUR AU - Oudin, M. J. AU - Weaver, V. M. PY - 2016 DA - 2016// TI - Physical and chemical gradients in the tumor microenvironment regulate tumor cell invasion, migration, and metastasis JO - Cold Spring HarbSymp Quant Biol VL - 81 UR - https://doi.org/10.1101/sqb.2016.81.030817 DO - 10.1101/sqb.2016.81.030817 ID - Oudin2016 ER - TY - JOUR AU - Jiang, L. AU - Lv, X. AU - Li, J. PY - 2012 DA - 2012// TI - The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma JO - Acta Histochem VL - 114 UR - https://doi.org/10.1016/j.acthis.2011.11.001 DO - 10.1016/j.acthis.2011.11.001 ID - Jiang2012 ER -